Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid and Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00003816
What this trial is testing

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Roswell Park Cancer Institute 361
Early research (Phase 1)Study completedNCT00526617
What this trial is testing

A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients

Who this might be right for
Non-hematologic MalignanciesMetastatic MelanomaBreast Cancer+4 more
AbbVie 41
Testing effectiveness (Phase 2)Study completedNCT00002504
What this trial is testing

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Hoag Memorial Hospital Presbyterian
Not applicableActive Not RecruitingNCT00935090
What this trial is testing

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Barbara Ann Karmanos Cancer Institute
Not applicableStudy completedNCT01866969
What this trial is testing

Quality of Life in Caregivers of Hospitalized Older Patients With Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerUnspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center 211
Not applicableStudy completedNCT05118802
What this trial is testing

Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Thomas Jefferson University 46
Not applicableUnknownNCT05455866
What this trial is testing

Central Venous Catheter-related Complications in Patients Under Anticancer Treatment

Who this might be right for
Central Venous Catheter ThrombosisCentral Venous Catheter Related Bloodstream InfectionSolid Tumor+1 more
Centre Hospitalier Alpes Leman 100
Testing effectiveness (Phase 2)Study completedNCT00526045
What this trial is testing

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerHematologic Neoplasms
Novartis Pharmaceuticals 117
Not applicableWithdrawnNCT04557709
What this trial is testing

Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center
Early research (Phase 1)Looking for participantsNCT07036133
What this trial is testing

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

Who this might be right for
Advanced Solid TumorsHematologic Malignancies
Acrotech Biopharma Inc. 24
Large-scale testing (Phase 3)Study completedNCT00750009
What this trial is testing

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Case Comprehensive Cancer Center 583
Testing effectiveness (Phase 2)Active Not RecruitingNCT06303167
What this trial is testing

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 19
Not applicableStudy completedNCT00769951
What this trial is testing

Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer

Who this might be right for
Cognitive/Functional EffectsDepressionHematopoietic/Lymphoid Cancer+5 more
Case Comprehensive Cancer Center 46
Not applicableUnknownNCT02213822
What this trial is testing

Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis

Who this might be right for
Solid TumorsHematological Malignancies
Rhode Island Hospital 500
Not applicableUnknownNCT03373656
What this trial is testing

Vaccination for Children of H&O and Their Parents

Who this might be right for
VaccinationHematologic MalignancySolid Tumor, Childhood
Children's Cancer Group, China 300
Early research (Phase 1)Study completedNCT01317927
What this trial is testing

Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies

Who this might be right for
Solid TumorHematological Malignancy
Spectrum Pharmaceuticals, Inc 27
Large-scale testing (Phase 3)Study completedNCT03080883
What this trial is testing

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Who this might be right for
Cerebral Vein ThrombosisDeep Vein ThrombosisHematopoietic and Lymphoid Cell Neoplasm+4 more
Academic and Community Cancer Research United 370
Testing effectiveness (Phase 2)Study completedNCT00894049
What this trial is testing

A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation

Who this might be right for
AllograftAllogeneic Cell TransplantaionHematological Malignancy+1 more
Institut Paoli-Calmettes 148
Early research (Phase 1)Study completedNCT02143635
What this trial is testing

Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt

Who this might be right for
Advanced Solid and Hematological TP53wt Tumors
Novartis Pharmaceuticals 208
Testing effectiveness (Phase 2)UnknownNCT05880043
What this trial is testing

GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies

Who this might be right for
Advanced Solid TumorsRelapsed/Refractory Non-Hodgkin LymphomaRelapsed/Refractory Multiple Myeloma
GI Cell, Inc. 50
Next Page